Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease.
作者信息
Sweet R D, Lee J E, McDowell F
出版信息
Trans Am Neurol Assoc. 1971;96:59-65.
PMID:5159130
Abstract
摘要
相似文献
1
Alpha-methyldopa as an adjunct to levodopa treatment of Parkinson's disease.α-甲基多巴作为左旋多巴治疗帕金森病的辅助药物。
Trans Am Neurol Assoc. 1971;96:59-65.
2
[Methyldopa and levodopa].
Zhonghua Yi Xue Za Zhi. 1974;7:439-41.
3
Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486).α-甲基多巴肼（MK-486）对帕金森病左旋多巴治疗的改良作用
Trans Am Neurol Assoc. 1971;96:55-8.
4
Synergism of levodopa by alpha methyldopa.左旋多巴与α-甲基多巴的协同作用。
Trans Am Neurol Assoc. 1971;96:231-4.
5
L-Dopa, B 6 , and alpha-methyldopa hydrazine.左旋多巴、维生素B6和α-甲基多巴肼。
Confin Neurol. 1973;35(3):186-92.
6
[Therapy of parkinsonian syndromes and plasmatic DOPA levels. Effects of L-DOPA and 3-OMD, administered alone or combined, with or without a decarboxylase inhibitor].
Rev Eur Etud Clin Biol. 1972 Jan;17(1):38-44.
7
Modification of levodopa effect by systemic decarboxylase inhibition.
Arch Neurol. 1973 Feb;28(2):91-5. doi: 10.1001/archneur.1973.00490200039004.
8
[L-DOPA with the decarboxylase inhibitor Ro 4-4602 in the treatment of Parkinson's disease].左旋多巴与脱羧酶抑制剂Ro 4-4602治疗帕金森病
Ned Tijdschr Geneeskd. 1972 Nov 25;116(48):2180-4.
9
[Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor].
Munch Med Wochenschr. 1973 Apr 20;115(16):711-3.
10
3-O-Methyldopa, L-dopa, and trihexyphenidyl in the treatment of Parkinson's disease.
Mayo Clin Proc. 1973 Mar;48(3):173-83.
引用本文的文献
1
Neuropsychiatric consequences of cardiovascular medications.心血管药物的神经精神方面后果。
Dialogues Clin Neurosci. 2007;9(1):29-45. doi: 10.31887/DCNS.2007.9.1/jchuffman.
Zotero 插件